| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a substance utilizable for elucidation, diagnosis and treatment of an onset mechanism of diseases caused in relation to a human MTG8, MTGR1, MTG16 and leukemic fusion protein AML1-MTG8 or a substance utilizable for research on intracellular processes such as transcription. <P>SOLUTION: The RNA has a binding activity for the MTG8 TAF domain obtained by an SELEX (systematic evolution of ligands by exponential enrichment) method. <P>COPYRIGHT: (C)2008,JPO&INPIT |
